Opaleye Management Inc. - 30 Dec 2022 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Role
10%+ Owner
Signature
Opaleye Management Inc., By: /s/ James Silverman, President
Issuer symbol
TARA
Transactions as of
30 Dec 2022
Net transactions value
+$41,949
Form type
4
Filing time
30 Dec 2022, 17:00:30 UTC
Previous filing
14 Dec 2022
Next filing
13 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARA Common Stock, par value $0.001 per share Sale $35,713 +13,173 +0.52% $2.71 2,562,594 30 Dec 2022 By Opaleye, L.P. F1, F3
transaction TARA Common Stock, par value $0.001 per share Sale $6,236 +2,300 +1.8% $2.71 130,000 30 Dec 2022 By Managed Account F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.
F2 Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.
F3 The prices reported above reflects the weighted average purchase price. These transactions were executed in multiple trades between $2.69 and $2.75. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased.